| Detected | Trial | Change |
|---|---|---|
| 2026-07-24 | NCT07699939 Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and… |
Recruitment opened |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-06 | NCT07750353 A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for… | Phase 2 | Not Yet Recruiting |
| 2026-07-22 | NCT07720258 Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT04328948 | A Randomized Controlled Trial Evaluating of Prophylactic Irradiation in CRT for cT1bN0M0… | Esophageal Squamous Cell Carcinoma | Recruiting |
| Phase 2 | |||
| NCT05832827 | First-line CBDCA/PTX/LEN/Pembrolizumab Combination for Previously Untreated Advanced or… | Untreated Advanced or Recurrent Thymic Carcinomas | Recruiting |
| NCT06159478 | Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer… | Low-grade Glioma | Recruiting |
| NCT04962867 | NCCH2006/MK010 Trial (FORTUNE Trial) | Advanced or Recurrent Solid Tumors | Recruiting |
| NCT07347314 | Enfortumab Vedotin in Patients With Advanced Small Bowel Adenocarcinoma Refractory or… | Advanced Small Bowel Adenocarcinoma | Recruiting |
| NCT06673628 | Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma Patients | Angiosarcoma of Skin | Recruiting |
| NCT07699939 | Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and… | Gastric Adenocarcinoma | Recruiting |
| NCT07720258 | Sacituzumab Tirumotecan (MK-2870) in Patients With Advanced Small Bowel Adenocarcinoma… | Advanced Small Bowel Adenocarcinoma | Not Yet Recruiting |
| NCT07750353 | A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for… | Unresectable Thymic Carcinoma | Not Yet Recruiting |
| Not specified | |||
| NCT05217407 | Marker Assisted Selective ThErapy in Rare Cancers: Knowledge Database Establishing… | Rare Malignant Neoplasm | Recruiting |
| NCT05433753 | Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting… | HER2-positive Breast Cancer | Recruiting |
| NCT06854939 | A Prospective Study Investigating the Relationship Between Minimal Residual Disease… | NSCLC, Stage I, II, III | Not Yet Recruiting |